Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $49,452.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 2,600 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $19.02, for a total value of $49,452.00. Following the transaction, the chief financial officer directly owned 166,659 shares in the company, valued at approximately $3,169,854.18. The trade was a 1.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Omada Health Price Performance

Shares of OMDA traded up $1.99 during midday trading on Friday, reaching $20.89. 3,310,497 shares of the stock were exchanged, compared to its average volume of 946,807. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The company has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37. The business’s 50-day moving average price is $16.51 and its 200 day moving average price is $14.85.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million for the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities research analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Omada Health

Several hedge funds have recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new position in Omada Health in the 2nd quarter valued at $32,000. Bellevue Group AG raised its position in Omada Health by 0.7% during the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after buying an additional 1,791 shares during the last quarter. Quarry LP acquired a new stake in shares of Omada Health in the 4th quarter worth $29,000. Barclays PLC boosted its holdings in shares of Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after acquiring an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health in the fourth quarter valued at about $32,000.

Wall Street Analyst Weigh In

Several research firms recently commented on OMDA. Wells Fargo & Company upped their price target on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Barclays lifted their price objective on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 target price on shares of Omada Health in a report on Friday, May 8th. Citizens Jmp raised their price target on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. Finally, JPMorgan Chase & Co. dropped their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and an average price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.